Starting Dose of Sorafenib for the Treatment of Hepatocellular Carcinoma: A Retrospective, Multi-Institutional StudyKim A. Reiss, David E. Kaplan, Kathryn D’Addeo et al.|Journal of Clinical Oncology|2017Cited by 98
Risk of Hepatocellular Carcinoma After Spontaneous Clearance of Hepatitis C Virus and in Noncirrhosis Chronic Hepatitis C Patients With Sustained Virological Response: A Systematic ReviewChristine Hsu, David E. Kaplan, Harish Gopalakrishna et al.|Clinical Infectious Diseases|2023Cited by 12